These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 22396159)

  • 1. The structural biology of the FGF19 subfamily.
    Beenken A; Mohammadi M
    Adv Exp Med Biol; 2012; 728():1-24. PubMed ID: 22396159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C-terminal tail of FGF19 determines its specificity toward Klotho co-receptors.
    Wu X; Lemon B; Li X; Gupte J; Weiszmann J; Stevens J; Hawkins N; Shen W; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2008 Nov; 283(48):33304-9. PubMed ID: 18829467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular insights into the klotho-dependent, endocrine mode of action of fibroblast growth factor 19 subfamily members.
    Goetz R; Beenken A; Ibrahimi OA; Kalinina J; Olsen SK; Eliseenkova AV; Xu C; Neubert TA; Zhang F; Linhardt RJ; Yu X; White KE; Inagaki T; Kliewer SA; Yamamoto M; Kurosu H; Ogawa Y; Kuro-o M; Lanske B; Razzaque MS; Mohammadi M
    Mol Cell Biol; 2007 May; 27(9):3417-28. PubMed ID: 17339340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Klotho coreceptors inhibit signaling by paracrine fibroblast growth factor 8 subfamily ligands.
    Goetz R; Ohnishi M; Ding X; Kurosu H; Wang L; Akiyoshi J; Ma J; Gai W; Sidis Y; Pitteloud N; Kuro-O M; Razzaque MS; Mohammadi M
    Mol Cell Biol; 2012 May; 32(10):1944-54. PubMed ID: 22451487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The FGF metabolic axis.
    Li X
    Front Med; 2019 Oct; 13(5):511-530. PubMed ID: 31495905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique FGF23 with the ability to activate FGFR signaling through both αKlotho and βKlotho.
    Wu X; Weiszmann J; Ge H; Baribault H; Stevens J; Hawkins N; Vonderfecht S; Gardner J; Gupte J; Sheng J; Wang M; Li Y
    J Mol Biol; 2012 Apr; 418(1-2):82-9. PubMed ID: 22370560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis for FGF hormone signalling.
    Chen L; Fu L; Sun J; Huang Z; Fang M; Zinkle A; Liu X; Lu J; Pan Z; Wang Y; Liang G; Li X; Chen G; Mohammadi M
    Nature; 2023 Jun; 618(7966):862-870. PubMed ID: 37286607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structures of ligand-occupied β-Klotho complexes reveal a molecular mechanism underlying endocrine FGF specificity and activity.
    Kuzina ES; Ung PM; Mohanty J; Tome F; Choi J; Pardon E; Steyaert J; Lax I; Schlessinger A; Schlessinger J; Lee S
    Proc Natl Acad Sci U S A; 2019 Apr; 116(16):7819-7824. PubMed ID: 30944224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structures of β-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling.
    Lee S; Choi J; Mohanty J; Sousa LP; Tome F; Pardon E; Steyaert J; Lemmon MA; Lax I; Schlessinger J
    Nature; 2018 Jan; 553(7689):501-505. PubMed ID: 29342135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hormone-like (endocrine) Fgfs: their evolutionary history and roles in development, metabolism, and disease.
    Itoh N
    Cell Tissue Res; 2010 Oct; 342(1):1-11. PubMed ID: 20730630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Saga of Endocrine FGFs.
    Phan P; Saikia BB; Sonnaila S; Agrawal S; Alraawi Z; Kumar TKS; Iyer S
    Cells; 2021 Sep; 10(9):. PubMed ID: 34572066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue-specific expression of betaKlotho and fibroblast growth factor (FGF) receptor isoforms determines metabolic activity of FGF19 and FGF21.
    Kurosu H; Choi M; Ogawa Y; Dickson AS; Goetz R; Eliseenkova AV; Mohammadi M; Rosenblatt KP; Kliewer SA; Kuro-O M
    J Biol Chem; 2007 Sep; 282(37):26687-26695. PubMed ID: 17623664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Klotho gene family and the endocrine fibroblast growth factors.
    Kurosu H; Kuro-o M
    Curr Opin Nephrol Hypertens; 2008 Jul; 17(4):368-72. PubMed ID: 18660672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation.
    Goetz R; Nakada Y; Hu MC; Kurosu H; Wang L; Nakatani T; Shi M; Eliseenkova AV; Razzaque MS; Moe OW; Kuro-o M; Mohammadi M
    Proc Natl Acad Sci U S A; 2010 Jan; 107(1):407-12. PubMed ID: 19966287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGF23 signalling and physiology.
    Ho BB; Bergwitz C
    J Mol Endocrinol; 2021 Feb; 66(2):R23-R32. PubMed ID: 33338030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of a paracrine fibroblast growth factor into an endocrine fibroblast growth factor.
    Goetz R; Ohnishi M; Kir S; Kurosu H; Wang L; Pastor J; Ma J; Gai W; Kuro-o M; Razzaque MS; Mohammadi M
    J Biol Chem; 2012 Aug; 287(34):29134-46. PubMed ID: 22733815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Klotho proteins in health and disease.
    Kuro-O M
    Nat Rev Nephrol; 2019 Jan; 15(1):27-44. PubMed ID: 30455427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. betaKlotho is required for fibroblast growth factor (FGF) 21 signaling through FGF receptor (FGFR) 1c and FGFR3c.
    Suzuki M; Uehara Y; Motomura-Matsuzaka K; Oki J; Koyama Y; Kimura M; Asada M; Komi-Kuramochi A; Oka S; Imamura T
    Mol Endocrinol; 2008 Apr; 22(4):1006-14. PubMed ID: 18187602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Klotho and endocrine fibroblast growth factors: markers of chronic kidney disease progression and cardiovascular complications?
    Kuro-O M
    Nephrol Dial Transplant; 2019 Jan; 34(1):15-21. PubMed ID: 29800324
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Co-receptor requirements for fibroblast growth factor-19 signaling.
    Wu X; Ge H; Gupte J; Weiszmann J; Shimamoto G; Stevens J; Hawkins N; Lemon B; Shen W; Xu J; Veniant MM; Li YS; Lindberg R; Chen JL; Tian H; Li Y
    J Biol Chem; 2007 Oct; 282(40):29069-72. PubMed ID: 17711860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.